KESIMPTA is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS) including clinically isolated syndrome (CIS), relapsing-remitting... KESIMPTA, the KESIMPTA logo, and SENSOREADY are registered trademarks of Novartis AG. ALONGSIDE and the ALONGSIDE logo are trademarks of Novartis AG.

Access KESIMPTA resources including telemedicine tips, injection training videos, and information on starting treatment. See full prescribing & safety info.

Find the KESIMPTA style guide with brand assets such as logos, colors, fonts, and more.

KESIMPTA is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS) including clinically isolated syndrome (CIS), relapsing-remitting... Learn more about KESIMPTA, a relapsing multiple sclerosis (RMS) treatment option designed to be different. See full prescribing and safety information.

Ofatumumab (Kesimpta 20 mg solution for injection in pre-filled syringe/pen) is indicated for the treatment of relapsing forms of multiple sclerosis in adults. [9] [11] [16] The recommended dose is 20 mg of ofatumumab administered by subcutaneous injection with monthly dosing following loading. [17] [18]

View images of Kesimpta and identify pills by imprint code, shape and color with the Drugs.com Pill Identifier.

KESIMPTA is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Learn more about KESIMPTA® (ofatumumab), a b-cell injection treatment for Relapsing Multiple Sclerosis. See full Prescribing and Safety Information.

Douglas Jeffery, MD, and Stephanie Niemi-Olson, FNP, share how they explain to their patients how select adverse events such as PML and cancer risk are managed during therapy with KESIMPTA.

2025年1月17日 · Kesimpta (ofatumumab) is an FDA-approved medicine used to slow the progression and risk of relapses for specific forms of relapsing multiple sclerosis (MS). It is a once-a-month injection given under the skin (subcutaneously) that you …